These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18768318)

  • 1. Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists.
    Jitsuoka M; Tsukahara D; Ito S; Tanaka T; Takenaga N; Tokita S; Sato N
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5101-6. PubMed ID: 18768318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Ishikawa S; Sekino E; Sasaki T; Fujimura T; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Fukami T; Sato N
    J Med Chem; 2008 Aug; 51(15):4780-9. PubMed ID: 18598020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
    Hamill TG; Sato N; Jitsuoka M; Tokita S; Sanabria S; Eng W; Ryan C; Krause S; Takenaga N; Patel S; Zeng Z; Williams D; Sur C; Hargreaves R; Burns HD
    Synapse; 2009 Dec; 63(12):1122-32. PubMed ID: 19670309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Sekino E; Ishikawa S; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Sato N
    J Med Chem; 2008 Nov; 51(21):6889-901. PubMed ID: 18841880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.
    Roche O; Nettekoven M; Vifian W; Sarmiento RM
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4377-9. PubMed ID: 18606542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.
    Ishikawa M; Furuuchi T; Yamauchi M; Yokoyama F; Kakui N; Sato Y
    Bioorg Med Chem; 2010 Jul; 18(14):5441-8. PubMed ID: 20541426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity.
    Hudkins RL; Aimone LD; Bailey TR; Bendesky RJ; Dandu RR; Dunn D; Gruner JA; Josef KA; Lin YG; Lyons J; Marcy VR; Mathiasen JR; Sundar BG; Tao M; Zulli AL; Raddatz R; Bacon ER
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5493-7. PubMed ID: 21782432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists.
    Wijtmans M; Celanire S; Snip E; Gillard MR; Gelens E; Collart PP; Venhuis BJ; Christophe B; Hulscher S; van der Goot H; Lebon F; Timmerman H; Bakker RA; Lallemand BI; Leurs R; Talaga PE; de Esch IJ
    J Med Chem; 2008 May; 51(10):2944-53. PubMed ID: 18433114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.
    Dandu RR; Lyons JA; Raddatz R; Huang Z; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2151-3. PubMed ID: 22365751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology.
    Esbenshade TA; Yao BB; Witte DG; Carr TL; Sharma R; Baranowski JL; Krueger KM; Miller TR; Surber BW; Faghih R; Hancock AA
    Inflamm Res; 2005 Apr; 54 Suppl 1():S46-7. PubMed ID: 15928830
    [No Abstract]   [Full Text] [Related]  

  • 12. (11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists.
    Van Laere KJ; Sanabria-Bohórquez SM; Mozley DP; Burns DH; Hamill TG; Van Hecken A; De Lepeleire I; Koole M; Bormans G; de Hoon J; Depré M; Cerchio K; Plalcza J; Han L; Renger J; Hargreaves RJ; Iannone R
    J Nucl Med; 2014 Jan; 55(1):65-72. PubMed ID: 24263088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 3H-spiro[benzofuran-2,1'-cyclohexane] derivatives from naturally occurring filifolinol and their classical complement pathway inhibitory activity.
    Useglio M; Castellano PM; Operto MA; Torres R; Kaufman TS
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5097-101. PubMed ID: 16875818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.
    Kitbunnadaj R; Zuiderveld OP; Christophe B; Hulscher S; Menge WM; Gelens E; Snip E; Bakker RA; Celanire S; Gillard M; Talaga P; Timmerman H; Leurs R
    J Med Chem; 2004 May; 47(10):2414-7. PubMed ID: 15115383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a selective radioligand for melanin-concentrating hormone 1-receptor (MCH1R).
    Ito M; Sakamoto T; Suzuki T; Egashira S; Moriya M; Ishihara A; Iwaasa H; Matsushita H; Nakase K; Wallace MA; Dean D; Sato N; Tokita S; Kanatani A
    Bioorg Med Chem Lett; 2009 May; 19(10):2835-9. PubMed ID: 19361985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and classical pathway Complement inhibitory activity of C7-functionalized filifolinol derivatives, inspired in K-76 COOH.
    Larghi EL; Operto MA; Torres R; Kaufman TS
    Eur J Med Chem; 2012 Sep; 55():74-84. PubMed ID: 22835722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclopropane-based conformational restriction of histamine. (1S,2S)-2-(2-aminoethyl)-1-(1H-imidazol-4-yl)cyclopropane, a highly selective agonist for the histamine H3 receptor, having a cis-cyclopropane structure.
    Kazuta Y; Hirano K; Natsume K; Yamada S; Kimura R; Matsumoto S; Furuichi K; Matsuda A; Shuto S
    J Med Chem; 2003 May; 46(10):1980-8. PubMed ID: 12723960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
    Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
    J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity.
    Sundar BG; Bailey TR; Dunn D; Hostetler GA; Chatterjee S; Bacon ER; Yue C; Schweizer D; Aimone LD; Gruner JA; Lyons J; Raddatz R; Lesur B
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1546-9. PubMed ID: 22297111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.
    Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.